In the case of breast cancer, the activation of GPER results in the suppression of nuclear factor kappa B (NF-κB) transcription, thereby decreasing the production of IL-6 induced by TNFα in the SKBR3 cell line. This evidence concerns the gene GPER1 and breast cancer.